$9.80
-0.15-1.51%
Last update: Nov 6, 4:00 PM
ImmuCell Corp (ICCC) Stock Price, Quote, News & History
ICCCNASDAQ
Animal health company ImmuCell receives an Incomplete Letter from the FDA for its Re-Tain NADA. Company shifts focus to First Defense.
You can purchase shares of ImmuCell (NASDAQ:ICCC) through any online brokerage.
Other companies in ImmuCell’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for ImmuCell to provide a consensus price target.
The stock price for ImmuCell (NASDAQ: ICCC) is $10.57 last updated November 4, 2026 at 5:23 PM EST.
There are no upcoming dividends for ImmuCell.
ImmuCell does not have any upcoming earnings scheduled.
There is no upcoming split for ImmuCell.
ImmuCell is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product,...
